Literature DB >> 15258410

Uveitis: a potentially blinding disease.

O M Durrani1, C A Meads, P I Murray.   

Abstract

Uveitis (intraocular inflammation) is a potentially blinding group of, probably autoimmune, conditions predominantly occurring in the working age group. Although the aetiology is unknown in most cases, many patients have an associated underlying systemic disease. Central vision loss, in the form of cystoid macular oedema, is the commonest type of visual impairment. Although historical incidence and prevalence data exists, little is known about the degree of vision loss experienced, and the social and financial consequences of having temporary or permanent visual impairment in this age group. The literature is also full of uncontrolled studies and case reports of different modalities of drug therapy for uveitis. This article attempts to raise the awareness of uveitis as an important sight-threatening group of conditions by highlighting the paucity of evidence-based data on epidemiological, quality of life, socioeconomic, and therapeutic aspects. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2004        PMID: 15258410     DOI: 10.1159/000078612

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  79 in total

1.  High-dose intravenous corticosteroids for ocular inflammatory diseases.

Authors:  Leon D Charkoudian; Gui-shuang Ying; Siddharth S Pujari; Sapna Gangaputra; Jennifer E Thorne; C Stephen Foster; Douglas A Jabs; Grace A Levy-Clarke; Robert B Nussenblatt; James T Rosenbaum; Eric B Suhler; John H Kempen
Journal:  Ocul Immunol Inflamm       Date:  2012-04       Impact factor: 3.070

2.  Associations among visual acuity and vision- and health-related quality of life among patients in the multicenter uveitis steroid treatment trial.

Authors:  Kevin D Frick; Lea T Drye; John H Kempen; James P Dunn; Gary N Holland; Paul Latkany; Narsing A Rao; H Nida Sen; Elizabeth A Sugar; Jennifer E Thorne; Robert C Wang; Janet T Holbrook
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-03-09       Impact factor: 4.799

3.  Risk of Noninfectious Uveitis with Female Hormonal Therapy in a Large Healthcare Claims Database.

Authors:  Lucia Sobrin; Yinxi Yu; Gayatri Susarla; Weilin Chan; Tian Xia; John H Kempen; Rebecca A Hubbard; Brian L VanderBeek
Journal:  Ophthalmology       Date:  2020-04-27       Impact factor: 12.079

4.  Cytokines in uveitis.

Authors:  J A M van Laar; P M van Hagen
Journal:  Clin Med Res       Date:  2006-12

5.  Superior sensitivity of novel molecular imaging probe: simultaneously targeting two types of endothelial injury markers.

Authors:  Dawei Sun; Shintaro Nakao; Fang Xie; Souska Zandi; Alexander Schering; Ali Hafezi-Moghadam
Journal:  FASEB J       Date:  2010-01-26       Impact factor: 5.191

6.  A collagen IV-derived peptide disrupts α5β1 integrin and potentiates Ang2/Tie2 signaling.

Authors:  Adam C Mirando; Jikui Shen; Raquel Lima E Silva; Zenny Chu; Nicholas C Sass; Valeria E Lorenc; Jordan J Green; Peter A Campochiaro; Aleksander S Popel; Niranjan B Pandey
Journal:  JCI Insight       Date:  2019-02-21

7.  Long-term results of therapy with mycophenolate mofetil in chronic non-infectious uveitis.

Authors:  Deshka Doycheva; Manfred Zierhut; Gunnar Blumenstock; Nicole Stuebiger; Christoph Deuter
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-07-01       Impact factor: 3.117

Review 8.  The role of infections in autoimmune disease.

Authors:  A M Ercolini; S D Miller
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

9.  Microbiota-Dependent Activation of an Autoreactive T Cell Receptor Provokes Autoimmunity in an Immunologically Privileged Site.

Authors:  Reiko Horai; Carlos R Zárate-Bladés; Patricia Dillenburg-Pilla; Jun Chen; Jennifer L Kielczewski; Phyllis B Silver; Yingyos Jittayasothorn; Chi-Chao Chan; Hidehiro Yamane; Kenya Honda; Rachel R Caspi
Journal:  Immunity       Date:  2015-08-18       Impact factor: 31.745

10.  OUTCOMES OF PARS PLANA VITRECTOMY FOR MACULAR HOLE IN PATIENTS WITH UVEITIS.

Authors:  Natalia F Callaway; Marco A Gonzalez; Yoshihiro Yonekawa; Lisa J Faia; Efrem D Mandelcorn; Rahul N Khurana; Mohamed G A Saleh; Phoebe Lin; Lucia Sobrin; Thomas A Albini
Journal:  Retina       Date:  2018-09       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.